Clinical trial
Cystoscopy and Hexyl 5-Aminolevulinate in Detecting Carcinoma In Situ in…
NCT00052637 · Photocure, Industry · Completed
Key facts
| NCT number | NCT00052637 |
|---|---|
| Title | Cystoscopy and Hexyl 5-Aminolevulinate in Detecting Carcinoma In Situ in Patients With Bladder Cancer |
| Official title | An Open, Comparative, Within Patient, Controlled Phase III, Multicenter Study Of HEXVIX Fluorescence Cystoscopy And White Light Cystoscopy In the Detection Of Carcinoma In Situ In Patients With Bladder Cancer |
| Lead sponsor | Photocure, Industry |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Bladder Cancer |
| Intervention type | Drug, Procedure |
| Interventions | hexaminolevulinate, biopsy, cystoscopy |
| Start date | Sep 1, 2001 |
| Primary completion | May 1, 2002 |
| First posted | Jan 27, 2003 |
| Last update posted | Oct 23, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: